Article thumbnail

Estimating the impact of expanded access to antiretroviral therapy on maternal, paternal and double orphans in sub-Saharan Africa, 2009-2020

By Aranka Anema, Christopher G Au-Yeung, Michel Joffres, Angela Kaida, Krisztina Vasarhelyi, Steve Kanters, Julio SG Montaner and Robert S Hogg
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2006). (US) Census Bureau: International Data Base (IDB) Population Estimates: Sub-Saharan Africa Region.
  2. (2009). Agency for International Development (USAID): Health Policy Initiative. AIM: A Computer Program for Making HIV/AIDS Projections and Examining the Demographic and Social Impacts of AIDS: Spectrum System of Policy Models.
  3. (2005). Agency for International Development (USAID): Health Policy Initiative. DemProj: A Computer Program for Making Population Projections (computer program),
  4. (2007). AIM: A computer program for making HIV/AIDS Projections and Examining the Demographic and Social Impacts of AIDS.
  5. (1994). Assessing the potential impact of the HIV-1 epidemic on orphanhood and the demographic structure of populations in sub-Saharan Africa. Population Studies
  6. (2009). Bangsberg DR: Antiretroviral Therapy is Associated with Increased Fertility Desire, but not Pregnancy or Live Birth,
  7. (2009). BG: Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet
  8. (2008). Calmy A: Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières. AIDS
  9. (2009). Children’s Fund (UNICEF): State of the World’s Children: Maternal and Newborn Health.
  10. (2007). CJ: Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PloS Med
  11. Discrepancies between UN models and DHS survey estimates of maternal orphan prevalence: insights from analyses of survey data from Zimbabwe. Sex Transm Inf 2008, 84(Suppl I):i57-i62.
  12. (2009). E: Orphanhood predicts delayed access to care in Ugandan children. Pediatr Infect Dis J
  13. Ekpini RE: The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds. Sex Transm Inf 2008, 84(Suppl 1):24-i30.
  14. (2009). Emotional development and nutritional status of HIV/AIDS orphaned children aged 6-12 years old in Thailand.
  15. (1984). Estimating adult mortality with maternal orphanhood data: analysis of sensitivity of the techniques. Popul Stud (Camb)
  16. (2006). Hogg R: The potential impact of antiretroviral therapy on fertility in sub-Saharan Africa. Curr HIV/AIDS Rep
  17. (2006). International Data Base(IDB): Table 028: Age-specific Fertility Rates and Selected Derived Measures,
  18. (2008). JR: From affected to infected? Orphanhood and HIV risk among female adolescents in urban Zimbabwe.
  19. (2007). L: Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann Intern Med
  20. (2008). MC: HIV-Associated Orphanhood and Children’s Psychosocial Distress: Theoretical Framework Tested With Data From Zimbabwe. Am J Public Health
  21. (1998). Measuring the impact of HIV on fertility in Africa.
  22. (1997). Montaner JS: Decline in deaths from AIDS due to new antiretrovirals. Lancet
  23. (2008). Montaner JS: Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis
  24. (2009). Montaner JS: The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr
  25. (2004). N: The UNAIDS Estimation and Projection Package: a software package to estimate and project national HIV epidemics. Sex Transm Infect
  26. (2006). Nations Programme on HIV/AIDS (UNAIDS), United Nations Children’s Fund (UNICEF), United States Agency for International Development (USAID): Africa’s Orphaned and Vulnerable Generations: Children Affected by AIDS.
  27. (2008). Nations Programme on HIV/AIDS (UNAIDS), World Health Organization (WHO) and United Nations Children’s Fund (UNICEF): Epidemiological fact sheets on HIV and AIDS.
  28. (2008). Nations Programme on HIV/AIDS (UNAIDS): Global Report on the HIV/AIDS Epidemic.
  29. (2008). Nyandiko WM: Association of antiretroviral and clinic adherence with orphan status among HIVinfected children in Western Kenya. J Acquir Immune Defic Syndr
  30. (2009). Organization (WHO), Joint United Nations Programme on HIV/AIDS (UNAIDS), United Nations Children’s Fund (UNICEF): Towards Universal Access: Scaling up priority HIV/AIDS interventions in the health sector. Progress Report
  31. (2004). Orphanhood and childcare patterns in subSaharan Africa: an analysis of national surveys from 40 countries. AIDS
  32. (2006). PR: The case for expanding access to highly active anti-retroviral therapy to curb the growth of the HIV epidemic. Lancet
  33. Projecting the demographic consequences of adult HIV prevalence trends: the Spectrum Projection Package. Sex Transm Inf 2004, 80(Suppl 1):i14-i18.
  34. (2000). RH: Viral load and heterosexual transmission of human immunodeficiency virus type 1, Rakai Project Study Group.
  35. (1998). Rising incidence and prevalence of orphanhood in
  36. (2011). Routes of Infection: Exports and HIV Incidence in Sub-Saharan Africa.
  37. (2009). The association of single and double orphanhood with symptoms of depression among children and adolescents in Namibia. Eur Child Adolesc Psychiatry
  38. (2001). The Impact of AIDS on Orphanhood in South Africa: A Quantitative Analysis. Centre for Actuarial Research (CARE) Mongraph
  39. (2004). Timaeus IM: Comparison of household-survey estimates with projections of mortality and orphan numbers in sub-Saharan Africa in the era of HIV/AIDS. Population Studies
  40. (2005). Timæus IM: Methods to Estimate the Number of Orphans as a Result of AIDS and Other Causes in Sub-Saharan Africa.
  41. Zaba B: Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy. AIDS 2007, 21(Suppl 6):S55-S63.